Notícias

According to the WHO news announcement, the monkeypox epidemic has found about 26,000 confirmed cases of monkeypox in more than 88 countries and regions, constituting the highest level of alert of "public health event of international concern (PHEIC)"! This has raised concerns about the spread of the virus. According to the WHO, Europe is currently a high-risk area for monkeypox, and the rest of the world is at a medium-risk level.

Em resposta ao surto global de monkeypox, a Lepu Medical desenvolveu um kit de teste de ácido nucleico (PCR-Fluorescence Probe Method) para o vírus monkeypox e obteve a certificação CE da UE. Este reagente fornece uma solução para ajudar os laboratórios em vários países a realizar eficientemente testes de ácido nucleico monkeypox e diagnóstico rápido.

Lepu Medical's monkeypox virus detection kit has the characteristics of high detection sensitivity, easy operability and strong stability. The kit can be quickly applied on multiple platforms such as Lepgen-96, Roche LightCycler 480 series, Bio-Rad CFX96, Shanghai Hongshi SLAN, and ABI 7500. At present, Lepu Medical has received orders and inquiries from many overseas countries and, at the same time, actively promotes the registration of this product in other overseas countries.